BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

ARBOR PHARMACEUTICALS, LLC — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Termination

ARBOR PHARMACEUTICALS, LLC

via THORN RUN PARTNERS

4th Quarter (Oct 1 - Dec 31) · 2017Posted Dec 19, 2017Filing document ↗LDA record ↗

Income$70Kfee reported

Client

Name: ARBOR PHARMACEUTICALS, LLC
Description: pharmaceutical company
Location: Georgia · United States of America

Registrant

Firm: THORN RUN PARTNERS
Description: Government Affairs Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Issues related to minority cardiovascular health.
LobbyistsANDREW ROSENBERG · ALEX DELPIZZO

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.